Policy | September 26, 2023
India to launch National Policy on Research and Development and Innovation in Pharma-MedTech
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)
Lupin has been exclusively marketing these brands in the Indian market since July 2021
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway
Reinforces Henkel commitment to supporting customers and ecosystem in medical healthcare
Fillauer recently announced the launch of the first-ever bio-attributed prosthetic foot shell
This X-ray device is not only low-dose but also lightweight, making it the perfect tool for quick & accurate diagnoses
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa
Subscribe To Our Newsletter & Stay Updated
